HealthEquity, Inc. (NASDAQ:HQY) Given Average Rating of “Moderate Buy” by Brokerages

Shares of HealthEquity, Inc. (NASDAQ:HQY) have earned an average recommendation of “Moderate Buy” from the fourteen research firms that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $110.71.

HQY has been the topic of a number of analyst reports. Royal Bank of Canada upped their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. Bank of America upped their price target on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. BTIG Research lifted their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research report on Thursday, November 14th. The Goldman Sachs Group initiated coverage on shares of HealthEquity in a report on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price on the stock. Finally, Mizuho assumed coverage on HealthEquity in a report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target for the company.

HealthEquity Stock Performance

Shares of HQY opened at $108.80 on Thursday. The stock has a market capitalization of $9.43 billion, a price-to-earnings ratio of 99.82, a PEG ratio of 1.86 and a beta of 0.54. HealthEquity has a 12 month low of $65.01 and a 12 month high of $111.36. The firm has a fifty day simple moving average of $99.85 and a 200 day simple moving average of $88.02. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter last year, the company earned $0.40 EPS. Research analysts forecast that HealthEquity will post 2.32 EPS for the current fiscal year.

Insider Buying and Selling at HealthEquity

In related news, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the sale, the director now directly owns 19,061 shares in the company, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction on Monday, December 9th. The stock was sold at an average price of $101.56, for a total value of $837,870.00. Following the transaction, the director now owns 66,469 shares in the company, valued at approximately $6,750,591.64. This trade represents a 11.04 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 34,289 shares of company stock valued at $3,355,718 in the last ninety days. 2.20% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. Wasatch Advisors LP boosted its holdings in shares of HealthEquity by 6.6% in the 3rd quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock valued at $635,065,000 after purchasing an additional 483,269 shares in the last quarter. State Street Corp boosted its stake in HealthEquity by 0.8% in the third quarter. State Street Corp now owns 3,131,900 shares of the company’s stock valued at $256,346,000 after buying an additional 23,613 shares in the last quarter. Clearbridge Investments LLC grew its position in HealthEquity by 1.9% in the second quarter. Clearbridge Investments LLC now owns 2,377,204 shares of the company’s stock valued at $204,915,000 after acquiring an additional 43,491 shares during the last quarter. Geode Capital Management LLC raised its stake in HealthEquity by 0.7% during the third quarter. Geode Capital Management LLC now owns 2,078,977 shares of the company’s stock worth $170,197,000 after acquiring an additional 15,145 shares in the last quarter. Finally, Franklin Resources Inc. lifted its holdings in shares of HealthEquity by 0.7% in the third quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company’s stock worth $139,369,000 after acquiring an additional 11,659 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.